Quick Hits: Kratom Recall, Eye Drug’s Alarming Side Effect & More

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

The FDA has recalled and destroyed kratom, a plant-based supplement, manufactured under several brands. Divinity Products Distribution, the manufacturer of the products, did so voluntarily. The move follows a previous warning from the FDA indicating that kratom can potentially be addictive since it has opioid-like qualities. The agency has suggested that all other companies selling products containing kratom follow suit by taking them off the market completely. Posted February 21, 2018. Via FDA.

Patients receiving a popular eye drug known as Eylea (aflibercept) have been experiencing an alarming side effect. Physicians identified an increase in a rare side effect associated with the macular degeneration and macular edema medication. Some people have experienced a sharp decline in sight, pain and a sudden panic episode shortly after receiving the eye injection. Last year, 1 in 10,000 people who received Eylea reported that they experienced the rare side effect, which is less than what the company identified in the clinical trials. Although the side effect doesn’t result in long-term vision loss and is said to be treatable, eye doctors are still recommending that people take precautions. Posted February 21, 2018. Via Bloomberg News.

The FDA expanded the approval of AstraZeneca’s immunotherapy drug Imfinzi (durvalumab) for the treatment of a type of lung cancer. The agency OK’d the drug to treat non-small cell lung cancer (NSCLC) in patients with stage III lung cancer, where the disease has not spread throughout the entire body. The biologic was already approved for bladder cancer. Some of the serious side effects associated with Imfinzi include immune-mediated side effects, where the body’s immune system attacks healthy cells or organs, such as the lungs, liver, colon, hormone-producing glands and kidneys. Posted February 16, 2018. Via FDA.


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement